Market Capital
₹1,791 Cr.
P/E
40.09
Share Price
₹ 1271.2 0.25 (0.02%)
Quick View
₹ 1271.2 0.25 (0.02%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Company Timeline

Forensics
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Other Income
Other Income is not affecting ratios of the company
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Debt
Company should not have issues servicing its debt
Current vs Historic Valuation
Company is trading at a premium to 3yr historic valuations
Working Capital
Working Capital of the company seems to be under control
Revenue Recognition
Company is converting accounting profit to cash
Capex vs ROCE
ROCE of the company has increased over the last three years
Share price
Share price has increased over last 10 years due to earnings
Contingent Liabilities
Company does not have significant contingent liabilities
Promoter Holding
Promoter has not sold any shares in the last 90 days
Retail Holding
Retail has been buying the stock which is usually a sign of exuberance
ROE
Latest
12.62%
3yr Average
11.11%
5yr Average
10.16%
Net Profit Margin
Latest
6.94%
3yr Average
6.2%
5yr Average
5.13%
ROCE
Latest
7.74%
3yr Average
7.35%
5yr Average
10.73%
Debt to Equity
Latest
0.06
3yr Average
0.08
5yr Average
0.11
Market Share
0% (as of Jul 22)
Anti - Diabetes - Market Share
0% (as of Jul 22)
Anti-Infectives - Market Share
0.02% (as of Nov 21)
Antineo Plastic - Market Share
0.23% (as of Nov 21)
Blood Related - Market Share
0% (as of Jul 22)
Cardiovascular - Market Share
0.01% (as of Nov 21)
Dermatology - Market Share
0.04% (as of Jul 22)
Gastro-Intestinal - Market Share
1.22% (as of Nov 21)
Gynecology - Market Share
0.20% (as of Nov 21)
Pain - Market Share
0.01% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.14% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.35% (as of Nov 21)
Urology - Market Share
0% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up -Pharmaceuticals

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up -Medical Devices

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Segment Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Operating Profit Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up -Segment

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • Management Compensation as a % of Sales (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Skore
    Company Filing
    Show Previous Years
    Discussions & Analysis